Microsoft Corporation vs. Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
MSFT
Microsoft Corporation
$487.46 -1.09%
VS TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$16.72 +0.97%
Microsoft Corporation (MSFT) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| MSFT | TAK | |
|---|---|---|
| Market Cap | $3.66 trillion | $53.40 billion |
| Revenue (TTM) | $331.84 billion | — |
| Net Income (TTM) | $133.75 billion | — |
MSFT leads on 1 of 1 size & scale factors.
Valuation
| MSFT | TAK | |
|---|---|---|
| P/E Ratio | 27.16 | — |
| Price / Book | 8.27 | — |
| Price / Sales | 11.03 | — |
MSFT and TAK split the valuation factors evenly.
Profitability
| MSFT | TAK | |
|---|---|---|
| Net Margin | 40.31% | — |
| Return on Equity | 30.23% | — |
MSFT and TAK split the profitability factors evenly.
Dividend
| MSFT | TAK | |
|---|---|---|
| Dividend Yield | 0.75% | 3.69% |
| Payout Ratio | 20.28 | — |
TAK leads on 1 of 1 dividend factors.
Risk & Sentiment
| MSFT | TAK | |
|---|---|---|
| Short Interest | 0.54% | 0.86% |
MSFT leads on 1 of 1 risk & sentiment factors.
Dig deeper: MSFT overview, MSFT financials, TAK overview, TAK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.